Hashizume; Yoshinobu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hashizume; Yoshinobu.The latest application filed is for "bmp-signal-inhibiting compound".

Company Profile

2.7.9

Hashizume; Yoshinobu - Saitama JP
Hashizume; Yoshinobu - Wako JP
Hashizume; Yoshinobu - Chita-gun JP
Hashizume; Yoshinobu - Aichi-ken JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
BMP-signal-inhibiting compound Grant 10,954,216 - Hashizume , et al. March 23, 2	2021-03-23
Bmp-signal-inhibiting Compound App 20190337926 - HASHIZUME; Yoshinobu ; et al.	2019-11-07
Agent for treating or inhibiting recurrence of acute myeloid leukemia Grant 9,604,988 - Ishikawa , et al. March 28, 2	2017-03-28
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents Grant 7,479,564 - Nakao , et al. January 20, 2	2009-01-20
Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidinopropanoic Acid Compounds as Orl-1-Receptor Antagonists App 20080207665 - Hashizume; Yoshinobu ; et al.	2008-08-28
Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidino Propanamide Compounds as Orl-1-Receptor Antagonists App 20080200490 - Hashizume; Yoshinobu ; et al.	2008-08-21
Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists Grant 7,354,925 - Hashizume , et al. April 8, 2	2008-04-08
Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists Grant 7,279,486 - Hashizume , et al. October 9, 2	2007-10-09
Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists App 20070197500 - Hashizume; Yoshinobu ; et al.	2007-08-23
Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents App 20070155732 - Nakao; Kazunari ; et al.	2007-07-05
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents Grant 7,141,580 - Nakao , et al. November 28, 2	2006-11-28
Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists App 20050277659 - Hashizume, Yoshinobu ; et al.	2005-12-15
Tetrahydroisoquinoline or isochroman compounds App 20050153998 - Ito, Fumitaka ; et al.	2005-07-14
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents App 20040181059 - Nakao, Kazunari ; et al.	2004-09-16
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents Grant 6,710,054 - Nakao , et al. March 23, 2	2004-03-23
Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents App 20020107273 - Nakao, Kazunnari ; et al.	2002-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.